Literature DB >> 23146901

Loss of pRB and p107 disrupts cartilage development and promotes enchondroma formation.

A S Landman1, P S Danielian, J A Lees.   

Abstract

The pocket proteins pRB, p107 and p130 have established roles in regulating the cell cycle through the control of E2F activity. The pocket proteins regulate differentiation of a number of tissues in both cell cycle-dependent and -independent manners. Prior studies showed that mutation of p107 and p130 in the mouse leads to defects in cartilage development during endochondral ossification, the process by which long bones form. Despite evidence of a role for pRB in osteoblast differentiation, it is unknown whether it functions during cartilage development. Here, we show that mutation of Rb in the early mesenchyme of p107-mutant mice results in severe cartilage defects in the growth plates of long bones. This is attributable to inappropriate chondrocyte proliferation that persists after birth and leads to the formation of enchondromas in the growth plates as early as 8 weeks of age. Genetic crosses show that development of these tumorigenic lesions is E2f3 dependent. These results reveal an overlapping role for pRB and p107 in cartilage development, endochondral ossification and enchondroma formation that reflects their coordination of cell-cycle exit at appropriate developmental stages.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23146901      PMCID: PMC3931423          DOI: 10.1038/onc.2012.496

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  50 in total

1.  Rb is critical in a mammalian tissue stem cell population.

Authors:  Pamela L Wenzel; Lizhao Wu; Alain de Bruin; Jean-Leon Chong; Wen-Yi Chen; Geoffrey Dureska; Emily Sites; Tony Pan; Ashish Sharma; Kun Huang; Randall Ridgway; Kishore Mosaliganti; Richard Sharp; Raghu Machiraju; Joel Saltz; Hideyuki Yamamoto; James C Cross; Michael L Robinson; Gustavo Leone
Journal:  Genes Dev       Date:  2007-01-01       Impact factor: 11.361

2.  Deregulated E2f-2 underlies cell cycle and maturation defects in retinoblastoma null erythroblasts.

Authors:  Alexandra Dirlam; Benjamin T Spike; Kay F Macleod
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

3.  Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues.

Authors:  Tiziana Parisi; Tina L Yuan; Ann Marie Faust; Alicia M Caron; Roderick Bronson; Jacqueline A Lees
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

4.  Essential role of retinoblastoma protein in mammalian hair cell development and hearing.

Authors:  Cyrille Sage; Mingqian Huang; Melissa A Vollrath; M Christian Brown; Philip W Hinds; David P Corey; Douglas E Vetter; Zheng-Yi Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

5.  Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation.

Authors:  Tri Dung Tiet; Sevan Hopyan; Puviindran Nadesan; Nalan Gokgoz; Raymond Poon; Alvin C Lin; Taiqiang Yan; Irene L Andrulis; Benjamin A Alman; Jay S Wunder
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

6.  Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.

Authors:  Seth D Berman; Eliezer Calo; Allison S Landman; Paul S Danielian; Emily S Miller; Julie C West; Borel Djouedjong Fonhoue; Alicia Caron; Roderick Bronson; Mary L Bouxsein; Siddhartha Mukherjee; Jacqueline A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

7.  Age-related changes in trabecular architecture differ in female and male C57BL/6J mice.

Authors:  Vaida Glatt; Ernesto Canalis; Lisa Stadmeyer; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2007-08       Impact factor: 6.741

8.  A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma.

Authors:  S Boeuf; P Kunz; T Hennig; B Lehner; Pcw Hogendoorn; Jvmg Bovée; W Richter
Journal:  J Pathol       Date:  2008-10       Impact factor: 7.996

9.  Mouse development with a single E2F activator.

Authors:  Shih-Yin Tsai; Rene Opavsky; Nidhi Sharma; Lizhao Wu; Shan Naidu; Eric Nolan; Enrique Feria-Arias; Cynthia Timmers; Jana Opavska; Alain de Bruin; Jean-Leon Chong; Prashant Trikha; Soledad A Fernandez; Paul Stromberg; Thomas J Rosol; Gustavo Leone
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

10.  Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease.

Authors:  Carl R Walkley; Rameez Qudsi; Vijay G Sankaran; Jennifer A Perry; Monica Gostissa; Sanford I Roth; Stephen J Rodda; Erin Snay; Patricia Dunning; Frederic H Fahey; Frederick W Alt; Andrew P McMahon; Stuart H Orkin
Journal:  Genes Dev       Date:  2008-06-15       Impact factor: 11.361

View more
  5 in total

1.  Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family.

Authors:  Tyler J Liban; Edgar M Medina; Sarvind Tripathi; Satyaki Sengupta; R William Henry; Nicolas E Buchler; Seth M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 2.  Enchondromatosis and Growth Plate Development.

Authors:  Hongyuan Zhang; Benjamin A Alman
Journal:  Curr Osteoporos Rep       Date:  2020-12-11       Impact factor: 5.096

3.  p107-Dependent recruitment of SWI/SNF to the alkaline phosphatase promoter during osteoblast differentiation.

Authors:  Stephen Flowers; Parth J Patel; Stephanie Gleicher; Kamal Amer; Eric Himelman; Shruti Goel; Elizabeth Moran
Journal:  Bone       Date:  2014-08-23       Impact factor: 4.398

4.  Regulation of Rb family proteins by Cdk6/Ccnd1 in growth plates.

Authors:  Toshihisa Komori
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

Review 5.  Cell Death in Chondrocytes, Osteoblasts, and Osteocytes.

Authors:  Toshihisa Komori
Journal:  Int J Mol Sci       Date:  2016-12-06       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.